Search research articles
Contact Us
Filters
Showing results (61-70 of 104) with videos related to
Page
of 11
Sort By:
Cancer Treatment Reports
|
August 1, 1982
Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation
R T Eagan, R P Dinapoli, R C Hermann, et al.
Cancer Treatment Reports
|
January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancer
W C Nichols, R T Eagan, S Frytak, et al.
Cancer Treatment Reports
|
March 1, 1984
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study
J E Krook, T R Fleming, R T Eagan, et al.
Cancer Clinical Trials
|
January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
American Journal of Clinical Oncology
|
June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP
R T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports
|
August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung
R T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports
|
May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers
R T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology
|
April 1, 1987
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports
|
September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung
R T Eagan, S Frytak, E T Creagan, et al.
Journal of Neuro-Oncology
|
January 1, 1987
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors
R T Eagan, R P Dinapoli, T L Cascino, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 104) with videos related to
Sort By:
Page
of 11
Cancer Treatment Reports
|
August 1, 1982
Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation
R T Eagan, R P Dinapoli, R C Hermann, et al.
Cancer Treatment Reports
|
January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancer
W C Nichols, R T Eagan, S Frytak, et al.
Cancer Treatment Reports
|
March 1, 1984
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study
J E Krook, T R Fleming, R T Eagan, et al.
Cancer Clinical Trials
|
January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
American Journal of Clinical Oncology
|
June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP
R T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports
|
August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung
R T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports
|
May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers
R T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology
|
April 1, 1987
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports
|
September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung
R T Eagan, S Frytak, E T Creagan, et al.
Journal of Neuro-Oncology
|
January 1, 1987
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors
R T Eagan, R P Dinapoli, T L Cascino, et al.
Page
of 11